Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

HIV Transmission Risk and Prevention

Baseline Transmission Probability

  • The per-act risk of HIV transmission from an HIV-positive female to an HIV-negative male through unprotected vaginal intercourse is approximately 1 in 700 to 1 in 3,000 exposures (0.03-0.14%) 1
  • The Centers for Disease Control and Prevention recommends considering the insertive vaginal intercourse (female-to-male) transmission risk, which is substantially lower than receptive exposures, with a risk of 1 in 700 to 1 in 3,000 per act 1
  • For comparison, male-to-female vaginal intercourse carries a higher risk at 1 in 200 to 1 in 2,000 (0.1-0.2%) 1

Critical Risk Modifiers That Dramatically Alter Transmission Probability

  • High viral load in the HIV-positive partner is the single most important risk amplifier, according to the CDC 2, 1
  • The presence of sexually transmitted infections (STIs) in either partner dramatically increases transmission through mucosal inflammation and increased viral shedding, as reported by the Infectious Diseases Society of America 3, 1
  • Genital ulcerative diseases (herpes, syphilis, chancroid) create entry points for the virus, increasing transmission risk 3
  • Trauma or bleeding during intercourse substantially elevates risk 1
  • Lack of male circumcision increases the receptive partner's risk 1
  • Recent HIV infection in the source partner (acute/primary infection phase) when viral loads are extremely high increases transmission risk 2

Prevention Strategies

  • Antiretroviral therapy with viral suppression in the HIV-positive partner reduces transmission risk by approximately 96%, according to the American College of Physicians 1
  • Pre-exposure prophylaxis (PrEP) in the HIV-negative partner provides substantial protection, as recommended by the CDC 1, 4
  • Consistent condom use reduces risk, but the exact percentage reduction is not specified in the provided references

Post-Exposure Management Algorithm

  • The CDC recommends seeking medical evaluation immediately if you have had a potential exposure within the last 72 hours, and starting post-exposure prophylaxis (PEP) using a 28-day course of combination antiretroviral therapy 2, 1, 5
  • PEP effectiveness decreases dramatically after 72 hours and is unlikely to provide benefit if started later, according to the CDC 2, 5
  • The World Health Organization recommends starting PEP immediately if the source partner is known to be HIV-positive, and considering starting if the source is from a high HIV prevalence group even if their status is unknown 2

Ongoing Risk Prevention

  • The CDC recommends pre-exposure prophylaxis (PrEP) for ongoing high-risk sexual practices, and comprehensive STI screening every 3-6 months at all exposure sites 1, 4
  • Partners with known HIV should achieve viral suppression through antiretroviral therapy, which reduces transmission by 96%, as recommended by the American College of Physicians 1

HIV Transmission Risk from Female to Circumcised Male

Baseline Transmission Risk

  • The per-act probability of HIV transmission from an HIV-positive female to an HIV-negative male through unprotected vaginal intercourse is approximately 1 in 700 to 1 in 3,000 exposures (0.03-0.14%) in uncircumcised men, according to the Centers for Disease Control and Prevention 6
  • For circumcised males, this already low baseline risk is reduced by an additional 53-60%, translating to approximately 70% overall protective effect, as recommended by the World Health Organization 7, 8

Protective Mechanism and Durability

  • The protective effect of circumcision is durable over time and has been demonstrated to be measurable at the population level in large-scale studies, as stated by the American College of Physicians 7
  • This protection is based on three landmark randomized controlled trials conducted in sub-Saharan Africa, which provide the highest quality evidence available, according to the National Institutes of Health 7, 8

Critical Risk Modifiers That Override Circumcision Protection

  • Presence of sexually transmitted infections (STIs) in either partner, particularly genital ulcerative diseases (herpes, syphilis, chancroid), creates mucosal inflammation and entry points that can negate circumcision's protective effect, as warned by the Centers for Disease Control and Prevention 7, 9

Essential Clinical Counseling Points

  • The 53-60% risk reduction from circumcision means that 40-47% of the baseline risk remains—this is substantial residual risk with repeated exposures, as noted by the World Health Organization 7, 8
  • Circumcision provides no direct protection to female partners from HIV-positive circumcised males, though population-level benefits may occur indirectly, according to the American College of Obstetricians and Gynecologists 7, 8

Comprehensive Prevention Strategy Required

  • Regular STI screening every 3-6 months at all exposure sites is critical, as STIs dramatically increase HIV transmission risk, as recommended by the Centers for Disease Control and Prevention 7, 9